Identify | Select | Assess
Third-Party Ultimate Beneficial Ownership
Third-Party Ultimate Beneficial Ownership
Third-Party Ultimate Beneficial Ownership
Ethixbase360’s Ultimate Beneficial Ownership data offers comprehensive intelligence on your third party’s beneficial owners and ownership structures. This allows your business to cost-effectively identify a third party’s UBO’s, select UBO’s based on % ownership thresholds, and assess the risk they pose – all within the Ethixbase360 Third Party Risk Management platform. Accelerate onboarding and operate with confidence knowing who you are doing business with.
Accelerate Onboarding • Mitigate Risks • Lower Costs
Ethixbase360 allows your business to accelerate third party due diligence at the time of onboarding with cost-effective embedded UBO data that enables your business to rapidly identify a third party’s Ultimate Beneficial Owners, select those that meet your thresholds, assess the sanctions risk they present and monitor throughout the course of your engagement.
Our comprehensive embedded UBO database includes:
- 120 global registries
- >310M Shareholder Records
- >390M global director and principal records
- >25M records from EU UBO/controller registers
Select identified UBO’s who meet your businesses % ownership thresholds to save in conjunction with the third-party record and assess sanctions risk against either 60 key sanctions and enforcements lists or over 21 million risk profiles for adverse media, sanctions and watchlists and over 3.1million profiles of politically exposed persons across 240 countries and territories.
Download Risk Guide: Unveiling the Power of UBO Data in Third-Party Due Diligence
Ultimate Beneficial Ownership Data is crucial for compliance and anti-corruption. This guide traces its evolution, to real cases like Petrobras and FIFA, it stresses UBO’s importance with OFAC and DOJ rules. Identifies PEPs and SOEs, and urges automation for accuracy. Global UBO register challenges persist due to jurisdiction variations.
Ready to get started?
Resources
Our Latest News, Case Studies, Webinars & More

Reputational Risk and Third-Party Exposure: Compliance Lessons from the Epstein Files
Recent disclosures linked to the Epstein case have reignited public scrutiny around reputational risk, third-party relationships, and the hidden vulnerabilities that sit beyond formal contracts [...]
Key Takeaways from Our London Roundtable: Human Rights Due Diligence in Pharma
We recently hosted a pharma-focused roundtable in partnership with Norton Rose Fulbright at their London office, bringing together senior risk and compliance professionals from across the life sciences industry. [...]
Economic Pressure, Perverse Incentives, and the Growing Importance of Third-Party Risk Management
The ongoing conflict in Iran has added fresh volatility to an already fragile global economic outlook in 2026, compounding uncertainty around tariffs, sanctions, and wider geopolitical tensions. [...]
Melbourne Seminar: Integrating Human Rights into Third-Party Risk Management: From Onboarding to Continuous Monitoring
Artificial intelligence is increasingly used in third-party risk management to help organizations manage scale, data volume, and ongoing monitoring requirements. [...]
Insights with Ethixbase360: Episode 1 – How Recipharm Approaches Third-Party Risk Management
Insights with Ethixbase360 is a video series featuring short conversations with compliance and risk leaders from across industries.[...]